A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2011
08/30/2011	US8007798 Treatment of complement-associated disorders
08/30/2011	CA2552600C Triaza-cyclopenta[cd]indene derivatives
08/30/2011	CA2526852C Use of 2h- [1,3] - oxazino [3,2-a] indole derivatives for the treatment of neuropathic pain
08/30/2011	CA2526052C Use of indazole derivatives for the treatment of neuropathic pain
08/30/2011	CA2493883C Drugs for improving the prognosis of brain injury and a method of screening the same
08/30/2011	CA2486298C Means for weaning people off smoking and alcohol
08/30/2011	CA2440473C Metalloproteinase inhibitors
08/30/2011	CA2438717C 6-phenylbenzonaphthyridines
08/30/2011	CA2436407C Polymer conjugates of neublastin and methods of using same
08/30/2011	CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
08/30/2011	CA2393352C Adamantane derivatives
08/25/2011	WO2011103510A1 Dha ester emulsions
08/25/2011	WO2011103471A1 Compositions and methods for the treatment of neurologic and psychiatric conditions
08/25/2011	WO2011103464A1 Methods and compositions for use in aquaculture
08/25/2011	WO2011103156A1 Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase
08/25/2011	WO2011103055A1 Glycine sulfonamides for use as inhibitors of diacylglycerol lipase
08/25/2011	WO2011102964A1 Heterocycles as potassium channel modulators
08/25/2011	WO2011102847A1 Compositions and methods for treatment of parkinson's disease
08/25/2011	WO2011102795A1 New crystalline form of a cyclopropyl benzamide derivative
08/25/2011	WO2011102793A1 Solid forms comprising a cyclopropyl amide derivative
08/25/2011	WO2011102404A1 Imidazole derivative
08/25/2011	WO2011102243A1 Neuropathic pain alleviating agent
08/25/2011	WO2011101881A2 Use of rho gtpase activating toxines for the treatment and/or prevention of symptomatology associated with rett syndrome
08/25/2011	WO2011101870A1 Fusion proteins for the treatment of multiple sclerosis and other autoimmune diseases
08/25/2011	WO2011101860A1 Nicotine-containing soft gelatin pastilles
08/25/2011	WO2011101774A1 (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
08/25/2011	WO2011101644A1 Triazolo [4, 5 - b] pyridin derivatives
08/25/2011	WO2011101374A1 Compositions comprising amphetamin and lisdexamfetamine
08/25/2011	WO2011101304A2 Piperidine derivatives
08/25/2011	WO2011076946A3 Methods and compositions for the treatment of alzheimer
08/25/2011	WO2011053675A3 Improved neurturin molecules
08/25/2011	WO2011032161A3 Vaccines directed to langerhans cells
08/25/2011	WO2010147434A3 Use of toosendanin or melia azedarach extracts for preventing or treating dementia
08/25/2011	WO2010087771A8 Compound and method for treatment of alzheimer's disease
08/25/2011	US20110208673 Antibodies to lymphotoxin-alpha
08/25/2011	US20110207911 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage
08/25/2011	US20110207830 Composition for treating or preventing amyloid-related diseases comprising 4-o-methylhonokiol
08/25/2011	US20110207828 Methods for the prevention and treatment of cerebral ischemia
08/25/2011	US20110207827 Method for determining sensitivity or resistance to compounds that activate the brain serotonin system
08/25/2011	US20110207813 Pharmaceutical composition with gelling properties containing a tyrosine derivative
08/25/2011	US20110207812 Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and -2,3-dihydro-1h-indenes as potassium channel modulators
08/25/2011	US20110207808 Long-chain carboxychromanols and analogs for use as anti-inflammatory agents
08/25/2011	US20110207802 Glutamic acid decarboxylase (gad) based delivery system
08/25/2011	US20110207796 Alpha-synuclein kinase
08/25/2011	US20110207795 Smad7 inhibitor compositions and uses thereof
08/25/2011	US20110207794 Pharmaceutical composition
08/25/2011	US20110207793 1-aminocyclohexane derivatives for the treatment of sleep disorders.
08/25/2011	US20110207791 Composition of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto
08/25/2011	US20110207790 Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
08/25/2011	US20110207788 5-Ring Heteroaromatic compounds and their use as binding partners for 5-ht5 receptors
08/25/2011	US20110207783 Renin inhibitors
08/25/2011	US20110207782 Nicotine-containing product
08/25/2011	US20110207777 Benzimidazoles which have activity at m1 receptor and their uses in medicine
08/25/2011	US20110207776 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
08/25/2011	US20110207773 Novel phenyl-quinoline-carboxylic acid pyridine derivatives useful as modulators of nicotinic acetylcholine receptors
08/25/2011	US20110207772 Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglycerol Lipase
08/25/2011	US20110207764 Cyclopolysaccharide compositions
08/25/2011	US20110207763 8-carboxamido-2,6-methano-3-benzazocines
08/25/2011	US20110207755 Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938
08/25/2011	US20110207753 Methods for treating pain
08/25/2011	US20110207750 Benzimidazole and aza-benzimidazole carboxamides
08/25/2011	US20110207749 Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglycerol Lipase
08/25/2011	US20110207748 Tri-Aryl/Heteroaromatic Cannabinoids and Use Thereof
08/25/2011	US20110207747 2,5-Disubstituted Phenyl Carboxamide Orexin Receptor Antagonists
08/25/2011	US20110207746 New compounds i
08/25/2011	US20110207745 Solid forms of 4--n,n-diethylbenzamide, compositions thereof, and uses therewith
08/25/2011	US20110207744 Method for treating cognitive deficits
08/25/2011	US20110207740 Pharmaceutical compositions
08/25/2011	US20110207738 Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
08/25/2011	US20110207735 Cyanopyrimidinones
08/25/2011	US20110207734 Azine Derivatives and Methods of Use Thereof
08/25/2011	US20110207733 Pyrimidine derivatives for treatment of alzheimer's disease
08/25/2011	US20110207730 Ion channel modulating compounds and uses thereof
08/25/2011	US20110207729 Bicyclic acylguanidine derivative
08/25/2011	US20110207726 Inhibitors of Human Cathepsin L, Cathepsin B, and Cathepsin S
08/25/2011	US20110207723 Novel fused aminodihydrothiazine derivative
08/25/2011	US20110207722 Treatment of anxiety disorders
08/25/2011	US20110207721 Purine derivatives as kinase inhibitors
08/25/2011	US20110207718 Compositions and methods for treating psychiatric disorders
08/25/2011	US20110207717 2-aminopyrimidine compounds as serotonin receptor modulators
08/25/2011	US20110207716 Inhibitors of polo-like kinase
08/25/2011	US20110207715 Disubstituted Azepan Orexin Receptor Antagonists
08/25/2011	US20110207714 Serotonin receptor modulators
08/25/2011	US20110207713 PYRIDO[3,2-d]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE
08/25/2011	US20110207711 Therapeutic Compounds
08/25/2011	US20110207709 Modulators of serotonin receptor
08/25/2011	US20110207704 Novel Oxadiazole Compounds
08/25/2011	US20110207700 Tricyclic compound and use thereof
08/25/2011	US20110207679 Methods of treatment using il-16 antagonist peptides
08/25/2011	US20110207672 Methods of treatment using a prodrug of an excitatory amino acid
08/25/2011	US20110207663 Fibroblast growth factor (fgf) analogs and uses thereof
08/25/2011	US20110207654 Peptide analogues
08/25/2011	US20110207224 In vivo production of small interfering rnas that mediate gene silencing
08/25/2011	US20110206783 P2x3, receptor antagonists for treatment of pain
08/25/2011	US20110206782 Piperidine modulators of dopamine receptor
08/25/2011	US20110206780 Morphinan modulators of nmda receptors, sigma1 receptors, sigma2 receptors, and/or a3b4 nicotinic receptors
08/25/2011	US20110206778 Treatment For Neuropathy, Shingles And Related Disorders
08/25/2011	US20110206769 Oral antidepressant formulation with reduced excipient load
08/25/2011	US20110206767 Pharmaceutical composition
08/25/2011	US20110206744 Modafinil formulations

1 ... 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 ... 1833